Rheon Medical receives CE mark approval for the eyeWatch system
Rheon Medical announced today that it has received CE mark approval for its first-in-class eyeWatch system used for the surgical treatment of glaucoma. Fore more information, find the press release here.
May 22, 2019
First publication on clinical results
J Glaucoma publication on first clinical results using the eyeWatch system demonstrates superior IOP management, prevention of ocular hypotony, substantial reduction in anti-glaucoma medication and low rate of complications (PDF)
June 07, 2018
First trial in the UK
The first eyeWatch system (eyeWatch and eyePlate) was implanted in the UK by Dr. Leon Au at the NHS Hospital in Manchester on June 6th, 2018. This first implantation is part of a 30 patient clinical trial to last over the next 18 months. For more information, click here.